Article Versions Notes

Alfahel L, Argueti-Ostrovsky S, Barel S, Ali Saleh M, Kahn J, Azoulay-Ginsburg S, Rothstein A, Ebbinghaus S, Gruzman A, Israelson A. 4-Phenylbutyric Acid (4-PBA) Derivatives Prevent SOD1 Amyloid Aggregation In Vitro with No Effect on Disease Progression in SOD1-ALS Mice. International Journal of Molecular Sciences. 2022; 23(16):9403. https://doi.org/10.3390/ijms23169403

Alfahel, Leenor, Shirel Argueti-Ostrovsky, Shir Barel, Mahmood Ali Saleh, Joy Kahn, Salome Azoulay-Ginsburg, Ayelet Rothstein, Simon Ebbinghaus, Arie Gruzman, and Adrian Israelson. 2022. "4-Phenylbutyric Acid (4-PBA) Derivatives Prevent SOD1 Amyloid Aggregation In Vitro with No Effect on Disease Progression in SOD1-ALS Mice" International Journal of Molecular Sciences 23, no. 16: 9403. https://doi.org/10.3390/ijms23169403

Alfahel, L., Argueti-Ostrovsky, S., Barel, S., Ali Saleh, M., Kahn, J., Azoulay-Ginsburg, S., Rothstein, A., Ebbinghaus, S., Gruzman, A., & Israelson, A. (2022). 4-Phenylbutyric Acid (4-PBA) Derivatives Prevent SOD1 Amyloid Aggregation In Vitro with No Effect on Disease Progression in SOD1-ALS Mice. International Journal of Molecular Sciences, 23(16), 9403. https://doi.org/10.3390/ijms23169403